References
- Kovacs K. Sheehan syndrome. Lancet 2003;361:520–2
- Goluboff LG, Ezrin C. Effect of pregnancy on the somatotroph and the prolactin cell of the human adenohypophysis. J Clin Endocrinol Metab 1969;29:1533–8
- Dejager S, Gerber S, Foubert L, Turpin G. Sheehan’s syndrome: differential diagnosis in the acute phase. J Intern Med 1998;244:261–6
- Keleştimur F. Sheehan's syndrome. Pituitary 2003;6:181–8
- De Bellis A, Kelestimur F, Sinisi AA, et al. Anti-hypothalamus and anti-pituitary antibodies may contribute to perpetuate the hypopituitarism in patients with Sheehan's syndrome. Eur J Endocrinol 2008;158:147–52
- Dökmetaş HS, Kilicli F, Korkmaz S, Yonem O. Characteristic features of 20 patients with Sheehan's syndrome. Gynecol Endocrinol 2006;22:279–83
- Fitzpatrick LA. Secondary causes of osteoporosis. Mayo Clin Proc 2002;77:453–68
- Gokalp D, Tuzcu A, Bahceci M, et al. Sheehan's syndrome and its impact on bone mineral density. Gynecol Endocrinol 2009;25:344–9
- Haddock L, Vega LA, Aguiló F, Rodriguez O. Adrenocortical, thyroidal and human growth hormone reserve in Sheehan’s syndrome. Johns Hopkins Med Bull 1972;131:80–99
- Sert M, Tetiker T, Kirim S, Kocak M. Clinical report of 28 patients with Sheehan’s syndrome. Endocr J 2003;50:297–301
- Okinaga H, Matsuno A, Okazaki R. High risk of osteopenia and bone derangement in postsurgical patients with craniopharyngiomas, pituitary adenomas and other parasellar lesions. Endocr J 2005;52:751–6
- Holmes SJ, Economou G, Whitehouse RW, et al. Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab 1994;78:669–74
- Kaufman JM, Taelman P, Vermeulen A, Vandeweghe M. Bone mineral status in growth hormone deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab 1992;74:118–23
- Popat VB, Calis KA, Vanderhoof VH, et al. Bone mineral density in estrogen-deficient young women. J Clin Endocrinol Metab 2009;94:2277–83
- Davies MC, Hall ML, Jacobs HS. Bone mineral loss in young women with amenorrhoea. BMJ 1990;301:790–3
- Meczekalski B, Podfigurna-Stopa A, Genazzani AR. Hypoestrogenism in young women and its influence on bone mass density. Gynecol Endocrinol 2010;26:652–7
- de Boer H, Blok GJ, Van Lingen A, et al. The consequences of childhood-onset growth hormone deficiency for adult bone mass. J Bone Miner Res 1994;9:1319–26
- Colao A, Di Somma C, Pivonello R, et al. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism. J Clin Endocrinol Metab 1999;84:1919–24
- Ahmad AM, Hopkins MT, Fraser WD, et al. Parathyroid hormone secretory pattern, circulating activity, and effect on bone turnover in adult growth hormone deficiency. Bone 2003;32:170–9
- Tanriverdi F, Unluhizarci K, Kula M, et al. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome. Growth Horm IGF Res 2005;15:231–7
- Degerblad M, Elgindy N, Hall K, et al. Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol 1992;126:387–93
- Johannsson G, Rosen T, Bosaeus I, et al. Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult onset GH deficiency. J Clin Endocrinol Metab 1996;81:2865–73